References

1. National Cancer Institute. Available at https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ac-t
2. Hilton J, Vandermeer L, Sienkiewicz M, Mazzarello S, Hutton B, Stober C, Fergusson D, Blanchette P, Joy AA, Brianne Bota A, Clemons M. Filgrastim use in patients receiving chemotherapy for early-stage breast cancer-a survey of physicians and patients. Support Care Cancer. 2018 Jul;26(7):2323-2331. doi: 10.1007/s00520-018-4074-8. Epub 2018 Feb 6. PMID: 29411131.
3. Clavel M, Soukop M, Greenstreet YL. Improved control of emesis and quality of life with ondansetron in breast cancer. Oncology. 1993 May-Jun;50(3):180-5. doi: 10.1159/000227174. PMID: 8459989.
4. Moo TA, Sanford R, Dang C, Morrow M. Overview of Breast Cancer Therapy. PET Clin. 2018 Jul;13(3):339-354. doi: 10.1016/j.cpet.2018.02.006. PMID: 30100074; PMCID: PMC6092031.
5. Barrio AV, Morrow M. Appropriate margin for lumpectomy excision of invasive breast cancer. Chin Clin Oncol. 2016 Jun;5(3):35. doi: 10.21037/cco.2016.03.22. Epub 2016 Apr 7. PMID: 27164854; PMCID: PMC4939766.
6. Vidic Z, Goricar K, Strazisar B, Besic N, Dolzan V. Association of OPRM1, MIR23B, and MIR107genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer. Radiol Oncol. 2023 Mar 22;57(1):111-120. doi: 10.2478/raon-2023-0003. PMID: 36942908; PMCID: PMC10039478.
7. Stallard S, Savioli F, McConnachie A, Norrie J, Dudman K, Morrow ES, Romics L. Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial. Br J Surg. 2022 Nov 22;109(12):1224-1231. doi: 10.1093/bjs/znac280. PMID: 35932230; PMCID: PMC10364710.
8. Upadhyay R, Bazan JG. Advances in Radiotherapy for Breast Cancer. Surg Oncol Clin N Am. 2023 Jul;32(3):515-536. doi: 10.1016/j.soc.2023.03.002. PMID: 37182990.